Table 1.
Feature | No. of patients (%) |
---|---|
Age, years (mean ± SD) | 67.1 ± 10.1 |
Sex | |
Female | 243 (53.5) |
Male | 211 (46.5) |
Type of cancer | |
Invasive IPMN | 78 (17.2) |
Non-IPMN-associated carcinoma | 376 (82.8) |
Tumor location | |
Tail | 229 (50.4) |
Body | 146 (32.2) |
Tail/body | 73 (16.1) |
Tail/body/head | 6 (1.3) |
Histopathologic differentiation | |
Well | 41 (9.0) |
Moderate | 271 (59.7) |
Poor | 128 (28.2) |
Unknown | 14 (3.1) |
T category, n (%) | |
T1 | 76 (16.7) |
T2 | 202 (44.5) |
T3 | 166 (36.6) |
Tx | 10 (2.2%) |
Lymph-node metastasis | |
Positive | 238 (52.4) |
Negative | 216 (47.6) |
Post-operative adjuvant chemotherapy | |
Yes | 84 (18.5) |
No | 303 (66.7) |
Unknown | 67 (14.8) |
Pathologic SA invasion | |
Present | 25 (5.5) |
Absent | 249 (54.8) |
Not reported | 180 (39.6) |
Pathologic SV invasion | |
Present | 53 (11.7) |
Absent | 220 (48.5) |
Not reported | 181 (39.9) |
Splenic parenchymal invasion | |
Present | 25 (5.5) |
Absent | 425 (93.6) |
Not reported | 4 (0.9) |
Radiographic SA invasion | |
Present | 73 (16.1) |
Absent | 242 (53.3) |
Not examined | 139 (30.6) |
Radiographic SV invasion | |
Present | 93 (20.5) |
Absent | 228 (50.2) |
Not examined | 133 (29.3) |
IPMN, intraductal papillary mucosal neoplasm; SA, splenic artery; SV, splenic vein; Tx, pathologic tumor stage not specified.